DERM Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States...

Stats
Today's Volume	294 894
Average Volume	120 519
Market Cap	75.24M
EPS	$0 ( 2023-11-19 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.89
ATR14	$0.0410 (1.01%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-28	Paley Jeffrey	Sell	1 745	Common Stock, par value $0.0001 per share
2023-10-13	Smith Justin Adam	Buy	33 000	Common Stock, par value $0.0001 per share
2023-10-06	Paley Jeffrey	Buy	15 000	Common Stock, par value $0.0001 per share
2023-09-21	Paley Jeffrey	Buy	30 000	Common Stock, par value $0.0001 per share
2023-09-06	Maraoui Claude	Buy	26 044	Common Stock, par value $0.0001 per share

INSIDER POWER
77.20
Last 33 transactions
Buy: 1 085 250 \| Sell: 583 822

Volume Correlation

Long: -0.07 (neutral)

Short: 0.03 (neutral)

Signal:(59.356) Neutral

Dermira Inc. Correlation

10 Most Positive Correlations
RMRM	0.942
VVOS	0.891
GETVV	0.878
XCUR	0.854
GAINL	0.846
ACST	0.825
GLMD	0.825
PASG	0.809

10 Most Negative Correlations
AMRB	-0.849
OZK	-0.815
SJ	-0.814

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dermira Inc. Correlation - Currency/Commodity

0.17
( neutral )

0.00
( neutral )

0.19
( neutral )

0.00
( neutral )

0.05
( neutral )

Dermira Inc. Financials

Annual	2022
Revenue:	$73.67M
Gross Profit:	$42.89M (58.23 %)
EPS:	$-1.690

Q3	2023
Revenue:	$34.54M
Gross Profit:	$28.11M (81.39 %)
EPS:	$0.910

Q2	2023
Revenue:	$17.17M
Gross Profit:	$9.41M (54.77 %)
EPS:	$-0.460

Q1	2023
Revenue:	$12.21M
Gross Profit:	$5.76M (47.20 %)
EPS:	$-0.560

Dermira Inc.

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.